Gallbladder, Bile Duct and Pancreas Disorders: Current Challenges, New Perspectives and Innovative Techniques

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "General Surgery".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 1428

Special Issue Editors


E-Mail Website
Guest Editor
First Propaedeutic Surgical Department, University Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece
Interests: pancreas; surgery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Surgical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
Interests: laparoscopic surgery; hernia; gastrectomy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
2nd Surgical Department, Aristotle University of Thessaloniki, “G. Gennimatas” Hospital, Thessaloniki, Greece
Interests: gastroenterology
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Emergency Department, University Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece
Interests: emergency medicine; internal medicine; diabetes; hypertension
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Gallbladder, bile duct and pancreas disorders are highly frequent and characterized by heterogeneity. Innovate technologies are used for the diagnosis and management of these disorders, allowing for the medical community to identify, locate and treat them. Entering this field, artificial intelligence is offering solutions to difficult cases of clinical practice. Additionally, minimally invasive surgical and endoscopic procedures, as well as robotic surgery, render higher chances for the successful management of the patients of these disorders. Moreover, oncology treatments are evolving, employing a wide range of biological medicines and opening a new era in therapy for gallbladder, bile duct and pancreas disorders.

The aim of this Special Issue is to evaluate and discuss current challenges, new perspectives and innovative techniques for gallbladder, bile duct and pancreas disorders, including differential diagnosis, pharmacotherapy, treatment, final outcome and prognosis.

We invite colleagues around the world to report their experience and knowledge with original studies, reviews, case reports or communications in current challenges, new perspectives and innovative techniques relating disorders of the gallbladder, bile ducts and pancreas for this Special Issue of our journal, in order to support this dominant research area.

You may choose our Joint Special Issue in Medicina.

Dr. Daniel Paramythiotis
Prof. Dr. Robert Grützmann
Prof. Dr. Vasileios Papaziogas
Dr. Dimitrios Raptis
Dr. Eleni Karlafti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pancreas
  • biliary tract
  • pancreatobiliary diseases
  • pancreas neoplasm
  • tumor
  • ERCP
  • EUS
  • management
  • therapy
  • technique
  • surgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

22 pages, 3683 KiB  
Systematic Review
Comparative Assessment of Endoscopic Ultrasound-Guided Biopsies vs. Percutaneous Biopsies of Pancreatic Lesions: A Systematic Review and Meta-Analysis of Diagnostic Performance
by Daniel Paramythiotis, Eleni Karlafti, Dimitrios Tsavdaris, Konstantinos Arvanitakis, Adonis A. Protopapas, Georgios Germanidis, Leonidas Kougias, Adam Hatzidakis, Christos Savopoulos and Antonios Michalopoulos
J. Clin. Med. 2024, 13(11), 3108; https://doi.org/10.3390/jcm13113108 - 25 May 2024
Viewed by 662
Abstract
Introduction: Pancreatic cancer ranks as the fourth deadliest form of cancer. However, it is essential to note that not all pancreatic masses signal primary malignancy. Therefore, it is imperative to establish the correct differential diagnosis, a process further supported by pre-operative biopsy procedures. [...] Read more.
Introduction: Pancreatic cancer ranks as the fourth deadliest form of cancer. However, it is essential to note that not all pancreatic masses signal primary malignancy. Therefore, it is imperative to establish the correct differential diagnosis, a process further supported by pre-operative biopsy procedures. This meta-analysis aims to compare the diagnostic performance of two minimally invasive biopsy approaches for pancreatic tissue sampling: percutaneous biopsies guided by computed tomography or ultrasound, and transduodenal biopsies guided by endoscopic ultrasound (EUS). Methods: A systematic literature search was conducted in the MEDLINE and Scopus databases. The included studies analyzed the diagnostic performance of the two biopsy methods, and they were assessed for risk of bias using the Quality Assessment of Diagnostic Accuracy Studies–2 tool. Statistical analysis was carried out using the RevMan and MetaDisc software packages. Results: The statistical analysis of the results demonstrated the superiority of the percutaneous approach. Specifically, the pooled sensitivity, specificity, LR+, LR−and DOR for the percutaneous approach were 0.896 [95% CI: 0.878–0.913], 0.949 [95% CI: 0.892–0.981], 9.70 [95% CI: 5.20–18.09], 0.20 [95% CI: 0.12–0.32] and 68.55 [95% CI: 32.63–143.98], respectively. The corresponding values for EUS-guided biopsies were 0.806 [95% CI: 0.775–0.834], 0.955 [95% CI: 0.926–0.974], 12.04 [95% CI: 2.67–54.17], 0.24 [95% CI: 0.15–0.39] and 52.56 [95% CI: 13.81–200.09], respectively. Nevertheless, it appears that this statistical superiority is also linked to the selection bias favoring larger and hence more readily accessible tumors during percutaneous biopsy procedures. Conclusions: Concisely, our meta-analysis indicates the statistical superiority of the percutaneous approach. However, selecting the optimal biopsy method is complex, influenced by factors like patient and tumor characteristics, clinical resources, and other relevant considerations. Full article
Show Figures

Figure 1

Back to TopTop